We transform the lives of people by developing innovative and life-changing medicines in Immunology, Oncology, Hematology, Cardiovascular, Metabolic, Neurosciences, Respiratory, Global Health, new platform therapies like Cell and Gene therapies, and many other therapeutic areas.
Novel therapy/ medicine’s journey starts from basic research (Biology, Chemistry) moves through Translational Research & Development (Clinical Trials phases) and ultimately to commercial use (once product is approved for commercial use).
The cross-functional research and development strategy and high-level plan for a specific asset (i.e. new medicine) development is supported by various units located in GDD Hyderabad - Clinical Development and Analytics, Global Development Operation, Chief Medical Office/Patient Safety Function, Global Development Quality (GDQ) Function, Regulatory Function, Translational Research and Development (Technical and Clinical Support) and Portfolio, Strategy and Management - Global Program Management.
The Novartis Institutes for BioMedical Research (NIBR) is the innovation engine of Novartis.
Pneumatic tube systems have existed for 150+ years and have transported everything from telegrams to aircraft parts. Now they’re being used in our labs.
A Cell & Gene production unit staffed by a highly trained team at Novartis will soon begin operating in Stein, Switzerland.
